KLK3 and cervical squamous cell carcinoma: HMGB1 has been demonstrated to work together with prostate specific antigen (PSA) for predicting biochemical recurrence in prostate cancer [20] or with squamous cell carcinoma antigen (SCCA) for early diagnosing recurrent cervical squamous cell carcinomas [32].